Saudi Central Bank Boosts Stake in Synopsys, Inc. $SNPS

Saudi Central Bank increased its stake in Synopsys, Inc. (NASDAQ:SNPS) by 80.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,739 shares of the semiconductor company’s stock after purchasing an additional 5,677 shares during the quarter. Saudi Central Bank’s holdings in Synopsys were worth $5,682,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Synopsys in the second quarter worth about $747,400,000. Norges Bank purchased a new position in shares of Synopsys in the fourth quarter worth $730,197,000. Man Group plc bought a new stake in Synopsys in the 2nd quarter valued at $55,900,000. SBI Okasan Asset Management Co.Ltd. bought a new position in shares of Synopsys during the 4th quarter valued at about $1,699,000. Finally, Czech National Bank grew its position in shares of Synopsys by 4.6% during the second quarter. Czech National Bank now owns 54,526 shares of the semiconductor company’s stock valued at $24,322,000 after purchasing an additional 2,421 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on SNPS shares. Mizuho dropped their price target on Synopsys from $600.00 to $550.00 and set an “outperform” rating for the company in a research report on Thursday, August 27th. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and increased their price target for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Zacks Research lowered shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 21st. Rosenblatt Securities reiterated a “buy” rating and set a $575.00 price objective on shares of Synopsys in a research report on Tuesday, August 25th. Finally, Morgan Stanley dropped their price target on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 19th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $561.28.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 24,641 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares in the company, valued at $50,518,611.92. This trade represents a 16.98% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 92,638 shares of company stock worth $40,747,732. 0.56% of the stock is currently owned by company insiders.

Synopsys Price Performance

Shares of SNPS opened at $393.84 on Monday. The firm has a fifty day moving average price of $412.27 and a 200-day moving average price of $439.48. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $75.48 billion, a P/E ratio of 69.58, a P/E/G ratio of 2.16 and a beta of 1.23. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $615.79.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm’s revenue was up 42.4% compared to the same quarter last year. During the same quarter last year, the firm posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.97 earnings per share for the current year.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys reported fiscal third-quarter revenue of approximately $2.48 billion and non-GAAP EPS of $3.91, exceeding analyst estimates of $2.44 billion and $3.67, respectively. Revenue grew 42.4% year over year, underscoring continued demand for electronic-design automation and semiconductor IP. Synopsys Results Analysis
• Positive Sentiment: Analysts continue to see significant long-term upside, with reported price targets generally ranging from $450 to $610 and a consensus “Moderate Buy” rating. The bullish case centers on Synopsys’ strategic importance to advanced chip and AI design. Synopsys Wall Street Price Targets
• Neutral Sentiment: Institutional positioning is mixed: 769 investors added SNPS shares in their latest reported quarter, while 764 reduced positions. This suggests continued interest but limited consensus among large investors. Synopsys Institutional Activity
• Negative Sentiment: The earnings beat did not translate into a sufficiently large outlook increase for a stock priced for stronger growth. Full-year guidance implies approximately $9.715 billion of revenue and $15.07 of non-GAAP EPS at the midpoint, prompting a potential “sell-the-news” reaction.
• Negative Sentiment: Investors remain concerned about execution and margin pressure from the Ansys integration. Synopsys reported roughly $236.3 million in restructuring charges during the first nine months of fiscal 2026, while acquired-intangible amortization and approximately $10 billion of debt add to acquisition-related financial risks. Synopsys Ansys Integration Analysis
• Negative Sentiment: Executive Chair Aart de Geus sold 49,641 shares for approximately $21.4 million across August 28, August 31 and September 1. The transactions were made under a pre-arranged Rule 10b5-1 plan, reducing their value as a discretionary bearish signal, but the selling may still weigh on sentiment. Synopsys Insider Selling
• Negative Sentiment: SNPS remains sensitive to higher interest rates and semiconductor-sector weakness. Its valuation remains demanding, with a reported P/E ratio above 69, while the stock is trading below its 200-day moving average. Is Synopsys Stock Underperforming the Nasdaq?

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.